What are the indications for Gaviscon and the recommended dosage for adults and children?

Gaviscon Dosing and Indications

For adults with mild-to-moderate heartburn and acid reflux, chew 2–4 Gaviscon tablets four times daily after meals and at bedtime, followed by a half glass of water; do not exceed 16 tablets in 24 hours or use maximum dosage for more than 2 weeks. 1

Adult Dosing

• Standard dose: Chew 2–4 tablets four times per day, taken after meals and at bedtime or as needed 1
• Administration: Must be chewed thoroughly and followed by a half glass of water or other liquid for optimal raft formation; do not swallow tablets whole 1
• Maximum daily limit: Do not exceed 16 tablets in any 24-hour period 1
• Duration limit: Do not use maximum dosage for more than 2 weeks without medical consultation 1

Indications

• Primary indication: Symptomatic relief of heartburn and acid reflux in patients with mild-to-moderate gastroesophageal reflux disease (GERD) 2, 3
• Mechanism: Gaviscon contains alginate plus antacid (aluminum hydroxide 160 mg and magnesium carbonate 105 mg per tablet), which forms a pH-neutral foam "raft" that floats on gastric contents and acts as a physical barrier during reflux episodes 1, 4
• Onset and duration: Raft formation occurs within seconds of dosing, providing rapid symptom relief comparable to traditional antacids but with longer-lasting effect (several hours) 4

Clinical Efficacy Evidence

• Versus placebo: A large randomized controlled trial (n=1,107) demonstrated that Gaviscon Double Action significantly reduced GERD symptoms compared to placebo, with benefit seen in both non-erosive and erosive reflux disease 2
• Versus omeprazole: A 14-day head-to-head trial showed Gaviscon was non-inferior to omeprazole 20 mg daily for achieving the first 24-hour heartburn-free period (mean 2.0 days for both), though omeprazole provided slightly more heartburn-free days by day 7 3
• Clinical positioning: Gaviscon represents an effective alternative to proton pump inhibitors for moderate episodic heartburn in primary care, particularly for patients seeking rapid on-demand relief 3

Precautions and Drug Interactions

• Consult a physician or pharmacist before use if: Taking prescription medications, as antacids may interact with certain drugs and interfere with absorption 1
• Sodium-restricted diets: Patients on sodium restriction should consult their doctor before use 1
• Specific drug interactions: Do not administer with baloxavir marboxil (antiviral) or other medications that require separation from polyvalent cations 5

Pediatric Considerations

• Infants and young children: While Gaviscon Infant formulations exist, one impedance/pH study in 20 infants showed only marginal reduction in reflux height with no significant difference in reflux frequency or acid clearance compared to placebo 6
• Guideline preference: Current American Academy of Pediatrics guidelines emphasize lifestyle modifications (smaller frequent feedings, thickening formula, maternal elimination diet, upright positioning) as first-line therapy for pediatric GERD, with acid suppression (PPIs or H2RAs) reserved for confirmed GERD with complications 7, 5
• Chronic antacid use: The AAP advises against chronic antacid therapy in toddlers due to safety concerns and lack of robust efficacy evidence; lifestyle modifications remain the safer first-line approach 5

Common Pitfalls to Avoid

• Do not swallow tablets whole—chewing is essential for proper alginate raft formation 1
• Do not exceed maximum daily dose (16 tablets/24 hours) or duration (2 weeks at maximum dose) without medical supervision 1
• Do not use as monotherapy for severe GERD—patients with alarm symptoms (dysphagia, weight loss, GI bleeding) require evaluation and likely need PPI therapy rather than antacids alone 5
• Do not assume pediatric safety—the evidence for Gaviscon in infants is limited and conflicting; prioritize conservative management in this population 6, 7